NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



US Retina Quarterly Update

出版商 Market Scope, LLC 商品編碼 960919
出版日期 年間契約型資訊服務 內容資訊 英文
美國的視網膜市場:季報 US Retina Quarterly Update
出版日期: 年間契約型資訊服務內容資訊: 英文




  • 各疾病及各產品的玻璃體內 (IVT) 注射
  • Eylea, Lucentis, Avastin, Macugen, Visudyne PDT的使用
  • 糖尿病黃斑部水腫 (DME) 治療
  • 皮質類固醇的使用
  • 光凝固數量和光凝固劑的使用
  • 玻璃體切除的數量與位置
  • 玻璃體切除機的使用與市場佔有率
  • 可重複使用、拋棄式的器具
  • 視覺化劑

更新資訊中,包含過去數年收集資訊的比較為基礎的趨勢分析。還有包含美國的視網膜手術 (IVT注射)的全年預測,及與前一年的比較。


Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our US Retina Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors' evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

We measure and analyze key metrics of the US retinal market four times per year, including:

  • IVT injections by disease and product;
  • Use of Eylea, Lucentis, Avastin, Macugen, and Visudyne PDT;
  • DME treatments;
  • Corticosteroid use;
  • Photocoagulation volume and photocoagulators used;
  • Vitrectomy volume and location;
  • Vitrectomy machine use and market share;
  • Reusable and disposable instruments.
  • Visualization agents

Our updates include trend analysis based on comparisons with information gathered in previous years. We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year.